Blood test can detect rejection of transplanted kidney

03/16/2012 | MedCityNews.com

A new molecular blood test uses RNA genetic markers to detect signs of renal failure following a kidney transplant. The test, which can identify kidney failure weeks before clinical symptoms manifest, can serve as a safer alternative to a renal biopsy, which can lead to graft injury or loss or bleeding, according to Quest Diagnostics.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR